Yarra
I really struggle to reply politely to you, because your post is so full of innuendo, guess work and your opinion
First you say Platinum are behind this to manufacture a better deal, tell us finance will definitely be changed but you don't know how exactly or what - I'll give you a hint, it is very easy to track stock across the register who and is selling/borrowing
Next you say management should have updated holders ? Well anyone who rang and spoke was given just that message you wanted - everything on track. It isn't Platinum's place to make announcements, and like you would believe it anyway. Had the ASX done their job and queried the company, that is their avenue for response. If more people complained rather than sat idle, the ASX might have done their job
Seems it's only me and a select 1 or 2 others who contact the company, ASIC or ASX. Perhaps if they had more demands from shareholders for an update they would
- Forums
- ASX - By Stock
- CKA
- Ann: Ceasing to be a substantial holder
CKA
cokal limited
Add to My Watchlist
3.03%
!
3.4¢

Ann: Ceasing to be a substantial holder, page-43
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
3.4¢ |
Change
0.001(3.03%) |
Mkt cap ! $36.68M |
Open | High | Low | Value | Volume |
3.4¢ | 3.5¢ | 3.4¢ | $16.21K | 465.5K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
3 | 287500 | 3.2¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
3.5¢ | 114731 | 2 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
3 | 287500 | 0.032 |
2 | 97701 | 0.031 |
1 | 50000 | 0.029 |
1 | 267000 | 0.028 |
2 | 172461 | 0.026 |
Price($) | Vol. | No. |
---|---|---|
0.035 | 114731 | 2 |
0.037 | 86000 | 1 |
0.049 | 14000 | 1 |
0.050 | 100000 | 1 |
0.060 | 65592 | 1 |
Last trade - 14.23pm 04/07/2025 (20 minute delay) ? |
Featured News
CKA (ASX) Chart |
The Watchlist
NUZ
NEURIZON THERAPEUTICS LIMITED
Dr Michael Thurn, CEO & MD
Dr Michael Thurn
CEO & MD
SPONSORED BY The Market Online